Skip to main content
Erschienen in: Wiener klinische Wochenschrift 8/2016

01.12.2016 | original article

The accuracy of combined use of troponin and red cell distribution width in predicting mortality of patients with acute pulmonary embolism

verfasst von: Selçuk Yazıcı, MD, Tuncay Kırış, MD, Ufuk S. Ceylan, MD, Şükrü Akyüz, MD, Ahmet O. Uzun, MD, Recep Hacı, MD, Sait Terzi, MD, Abdullah Doğan, MD, Ayşe Emre, MD, Kemal Yeşilçimen, MD

Erschienen in: Wiener klinische Wochenschrift | Sonderheft 8/2016

Einloggen, um Zugang zu erhalten

Summary

Background

Cardiac troponins and red cell distribution width (RDW) are associated with increased mortality in acute pulmonary embolism (PE). In this study, we aimed to investigate the accuracy of the combined use of troponin and RDW in predicting short-term mortality in acute PE patients.

Methods

The data of 201 patients with the diagnosis of acute PE were retrospectively analyzed. We obtained troponin–RDW scores (TR scores) using a combination of troponin and RDW values, and then evaluated this score’s accuracy in predicting mortality in patients with acute PE.

Results

The mean participant age was 68 ± 16 years, and 52 % of patients were female. Fifteen (7.4 %) patients died during the first month. Patients classified as high-risk according to TR scores were older (72 ± 15 vs. 66 ± 15 years, p = 0.005), and they had higher heart rates (101 ± 20 vs. 90 ± 15 beat/min, p < 0.001) and respiratory rates (23 ± 4 vs. 21 ± 3 breath/min, p = 0.001). In multivariate analysis, TR (odds ratio [OR] 4.93, 95 % confidence interval [CI] 1.13–21.38, p = 0.033) and simplified pulmonary embolism severity index (sPESI) scores (OR 3.78, 95 % CI 1.71–8.37, p = 0.002) were independent predictors of 30-day mortality. For 30-day mortality, the TR score had a slightly lower sensitivity (87 % vs. 93 %), but a higher specificity (69 % vs. 52 %) compared to the sPESI score.

Conclusion

The TR score is easy to calculate, and it may be used to predict early mortality in patients with acute PE.
Literatur
1.
Zurück zum Zitat Naess IA, Christiansen SC, Romundstad P, Hammerstrøm J, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692–9.CrossRefPubMed Naess IA, Christiansen SC, Romundstad P, Hammerstrøm J, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692–9.CrossRefPubMed
2.
Zurück zum Zitat Minges KE, Bikdeli B, Wang Y, et al. National trends in pulmonary embolism hospitalization rates and outcomes for adults aged ≥65 years in the united states (1999 to 2010). Am J Cardiol. 2015;116:1436–42.CrossRefPubMedPubMedCentral Minges KE, Bikdeli B, Wang Y, et al. National trends in pulmonary embolism hospitalization rates and outcomes for adults aged ≥65 years in the united states (1999 to 2010). Am J Cardiol. 2015;116:1436–42.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Goldhaber SZ, Visani L, Rosa M de. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386–9.CrossRefPubMed Goldhaber SZ, Visani L, Rosa M de. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353:1386–9.CrossRefPubMed
4.
Zurück zum Zitat Bova C, Sanchez O, Prandoni P, et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J. 2014;44:694–703.CrossRefPubMed Bova C, Sanchez O, Prandoni P, et al. Identification of intermediate-risk patients with acute symptomatic pulmonary embolism. Eur Respir J. 2014;44:694–703.CrossRefPubMed
5.
Zurück zum Zitat Zondag W, Mos IC, Creemers-Schild D, et al. Hestia Study Investigators. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost. 2011;9:1500–7.CrossRefPubMed Zondag W, Mos IC, Creemers-Schild D, et al. Hestia Study Investigators. Outpatient treatment in patients with acute pulmonary embolism: the Hestia Study. J Thromb Haemost. 2011;9:1500–7.CrossRefPubMed
6.
Zurück zum Zitat Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172:1041–6.CrossRefPubMedPubMedCentral Aujesky D, Obrosky DS, Stone RA, et al. Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med. 2005;172:1041–6.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Jiménez D, Aujesky D, Moores L, et al. RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170:1383–9.CrossRef Jiménez D, Aujesky D, Moores L, et al. RIETE Investigators. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. Arch Intern Med. 2010;170:1383–9.CrossRef
8.
Zurück zum Zitat Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133:628–32.PubMed Lippi G, Targher G, Montagnana M, et al. Relation between red blood cell distribution width and inflammatory biomarkers in a large cohort of unselected outpatients. Arch Pathol Lab Med. 2009;133:628–32.PubMed
10.
Zurück zum Zitat Patel KV, Mohanty JG, Kanapuru B, et al. Association of the red cell distribution width with red blood cell deformability. Adv Exp Med Biol. 2013;765:211–6.CrossRefPubMed Patel KV, Mohanty JG, Kanapuru B, et al. Association of the red cell distribution width with red blood cell deformability. Adv Exp Med Biol. 2013;765:211–6.CrossRefPubMed
11.
Zurück zum Zitat Kimmenade RR van, Mohammed AA, Uthamalingam S, et al. Red blood cell distribution width and 1‑year mortality in acute heart failure. Eur J Heart Fail. 2010;12:129–36.CrossRefPubMed Kimmenade RR van, Mohammed AA, Uthamalingam S, et al. Red blood cell distribution width and 1‑year mortality in acute heart failure. Eur J Heart Fail. 2010;12:129–36.CrossRefPubMed
12.
Zurück zum Zitat Tonelli M, Sacks F, Arnold M, et al. for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronarydisease. Circulation. 2008;117:163–8.CrossRef Tonelli M, Sacks F, Arnold M, et al. for the Cholesterol and Recurrent Events (CARE) Trial Investigators. Relation between red blood cell distribution width and cardiovascular event rate in people with coronarydisease. Circulation. 2008;117:163–8.CrossRef
13.
Zurück zum Zitat Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2009;277:103–8.CrossRefPubMed Ani C, Ovbiagele B. Elevated red blood cell distribution width predicts mortality in persons with known stroke. J Neurol Sci. 2009;277:103–8.CrossRefPubMed
14.
Zurück zum Zitat Zorlu A, Bektasoglu G, Guven FM, et al. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. Am J Cardiol. 2012;109:128–34.CrossRefPubMed Zorlu A, Bektasoglu G, Guven FM, et al. Usefulness of admission red cell distribution width as a predictor of early mortality in patients with acute pulmonary embolism. Am J Cardiol. 2012;109:128–34.CrossRefPubMed
15.
Zurück zum Zitat Ozsu S, Abul Y, Gunaydin S, et al. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clin Appl Thromb Hemost. 2014;20:365–70.CrossRefPubMed Ozsu S, Abul Y, Gunaydin S, et al. Prognostic value of red cell distribution width in patients with pulmonary embolism. Clin Appl Thromb Hemost. 2014;20:365–70.CrossRefPubMed
16.
Zurück zum Zitat Janata KM, Leitner JM, Holzer-Richling N, et al. Troponin T predicts in-hospital and 1‑year mortality in patients with pulmonary embolism. Eur Respir J. 2009;34:1357–63.CrossRefPubMed Janata KM, Leitner JM, Holzer-Richling N, et al. Troponin T predicts in-hospital and 1‑year mortality in patients with pulmonary embolism. Eur Respir J. 2009;34:1357–63.CrossRefPubMed
17.
Zurück zum Zitat Ng AC, Yong AS, Chow V, et al. Cardiac troponin-T and the prediction of acute and long-term mortality after acute pulmonary embolism. Int J Cardiol. 2013;165:126–33.CrossRefPubMed Ng AC, Yong AS, Chow V, et al. Cardiac troponin-T and the prediction of acute and long-term mortality after acute pulmonary embolism. Int J Cardiol. 2013;165:126–33.CrossRefPubMed
18.
Zurück zum Zitat Keller K, Beule J, Schulz A, et al. Cardiac troponin I for predicting right ventricular dysfunction and intermediate risk in patients with normotensive pulmonary embolism. Neth Heart J. 2015;23:55–61.CrossRefPubMed Keller K, Beule J, Schulz A, et al. Cardiac troponin I for predicting right ventricular dysfunction and intermediate risk in patients with normotensive pulmonary embolism. Neth Heart J. 2015;23:55–61.CrossRefPubMed
19.
Zurück zum Zitat Konstantinides SV, Torbicki A, Agnelli G, et al. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–69.CrossRef Konstantinides SV, Torbicki A, Agnelli G, et al. Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;35(43):3033–69.CrossRef
20.
Zurück zum Zitat Buller HR, Cohen AT, Davidson B, et al. van Gogh Investigators. Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med. 2007;357:1094–104.CrossRef Buller HR, Cohen AT, Davidson B, et al. van Gogh Investigators. Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med. 2007;357:1094–104.CrossRef
21.
Zurück zum Zitat Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72.CrossRefPubMed Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157–72.CrossRefPubMed
22.
Zurück zum Zitat Bessman JD, Gilmer PR Jr, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol. 1983;80:322–6.CrossRefPubMed Bessman JD, Gilmer PR Jr, Gardner FH. Improved classification of anemias by MCV and RDW. Am J Clin Pathol. 1983;80:322–6.CrossRefPubMed
23.
Zurück zum Zitat Bucciarelli P, Maino A, Felicetta I, et al. Association between red cell distribution width and risk of venous thromboembolism. Thromb Res. 2015;136:590–4.CrossRefPubMed Bucciarelli P, Maino A, Felicetta I, et al. Association between red cell distribution width and risk of venous thromboembolism. Thromb Res. 2015;136:590–4.CrossRefPubMed
24.
Zurück zum Zitat Biasucci LM, Liuzzo G, Angiolillo DJ, et al. Inflammation and acute coronary syndromes. Herz. 2000;25:108–12.CrossRefPubMed Biasucci LM, Liuzzo G, Angiolillo DJ, et al. Inflammation and acute coronary syndromes. Herz. 2000;25:108–12.CrossRefPubMed
25.
Zurück zum Zitat Marchena Yglesias PJ, Nieto Rodríguez JA, Serrano Martínez S, et al. Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters. An Med Interna. 2006;23:105–10.PubMed Marchena Yglesias PJ, Nieto Rodríguez JA, Serrano Martínez S, et al. Acute-phase reactants and markers of inflammation in venous thromboembolic disease: correlation with clinical and evolution parameters. An Med Interna. 2006;23:105–10.PubMed
26.
Zurück zum Zitat Engström G, Smith JG, Persson M, et al. Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med. 2014;276(2):174–83.CrossRefPubMed Engström G, Smith JG, Persson M, et al. Red cell distribution width, haemoglobin A1c and incidence of diabetes mellitus. J Intern Med. 2014;276(2):174–83.CrossRefPubMed
27.
Zurück zum Zitat Lee H, Kong SY, Sohn JY, et al. Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma. Biomed Res Int. 2014;2014:145619.PubMedPubMedCentral Lee H, Kong SY, Sohn JY, et al. Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma. Biomed Res Int. 2014;2014:145619.PubMedPubMedCentral
28.
Zurück zum Zitat Wen Y. High red blood cell distribution width is closely associated with risk of carotid artery atherosclerosis in patients with hypertension. Exp Clin Cardiol. 2010;15:37–40.PubMedPubMedCentral Wen Y. High red blood cell distribution width is closely associated with risk of carotid artery atherosclerosis in patients with hypertension. Exp Clin Cardiol. 2010;15:37–40.PubMedPubMedCentral
29.
Zurück zum Zitat Afonso L, Zalawadiya SK, Veeranna V, et al. Relationship between red cell distribution width and microalbuminuria: a population-based study of multiethnic representative US adults. Nephron Clin Pract. 2011;119:277–82.CrossRef Afonso L, Zalawadiya SK, Veeranna V, et al. Relationship between red cell distribution width and microalbuminuria: a population-based study of multiethnic representative US adults. Nephron Clin Pract. 2011;119:277–82.CrossRef
30.
Zurück zum Zitat Jiménez D, Aujesky D, Moores L, et al. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax. 2011;66:75–81.CrossRefPubMed Jiménez D, Aujesky D, Moores L, et al. Combinations of prognostic tools for identification of high-risk normotensive patients with acute symptomatic pulmonary embolism. Thorax. 2011;66:75–81.CrossRefPubMed
31.
Zurück zum Zitat Lankeit M, Jiménez D, Kostrubiec M, et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation. 2011;124:2716–24.CrossRefPubMed Lankeit M, Jiménez D, Kostrubiec M, et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation. 2011;124:2716–24.CrossRefPubMed
32.
Zurück zum Zitat Becattini C, Lignani A, Masotti L, et al. D‑dimer for risk stratification in patients with acute pulmonary embolism. J Thromb Thrombolysis. 2012;33:48–57.CrossRefPubMed Becattini C, Lignani A, Masotti L, et al. D‑dimer for risk stratification in patients with acute pulmonary embolism. J Thromb Thrombolysis. 2012;33:48–57.CrossRefPubMed
33.
Zurück zum Zitat Aujesky D, Roy PM, Guy M, et al. Prognostic value of D‑dimer in patients with pulmonary embolism. Thromb Haemost. 2006;96:478–82.PubMed Aujesky D, Roy PM, Guy M, et al. Prognostic value of D‑dimer in patients with pulmonary embolism. Thromb Haemost. 2006;96:478–82.PubMed
34.
Zurück zum Zitat Grau E, Tenías JM, Soto MJ, et al. D‑dimer levels correlate with mortality in patients with acute pulmonary embolism: findings from the RIETE registry. Crit Care Med. 2007;35:1937–41.CrossRefPubMed Grau E, Tenías JM, Soto MJ, et al. D‑dimer levels correlate with mortality in patients with acute pulmonary embolism: findings from the RIETE registry. Crit Care Med. 2007;35:1937–41.CrossRefPubMed
35.
Zurück zum Zitat Ghanima W, Abdelnoor M, Holmen LO, et al. D‑dimer level is associated with the extent of pulmonary embolism. Thromb Res. 2007;120:281–8.CrossRefPubMed Ghanima W, Abdelnoor M, Holmen LO, et al. D‑dimer level is associated with the extent of pulmonary embolism. Thromb Res. 2007;120:281–8.CrossRefPubMed
36.
Zurück zum Zitat Scherz N, Labarère J, Aujesky D, Méan M. Elevated admision glucose and mortality in patients with acute pulmonary embolism. Diabetes Care. 2012;35:25–31.CrossRefPubMed Scherz N, Labarère J, Aujesky D, Méan M. Elevated admision glucose and mortality in patients with acute pulmonary embolism. Diabetes Care. 2012;35:25–31.CrossRefPubMed
37.
Zurück zum Zitat Lippi G, Filippozzi L, Montagnana M, et al. Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute syndromes. Clin Chem Lab Med. 2009;47:353–7.PubMed Lippi G, Filippozzi L, Montagnana M, et al. Clinical usefulness of measuring red blood cell distribution width on admission in patients with acute syndromes. Clin Chem Lab Med. 2009;47:353–7.PubMed
38.
Zurück zum Zitat Moores L, Aujesky D, Jiménez D, et al. Pulmonary Embolism Severity Index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism. J Thromb Haemost. 2010;8:517–22.CrossRefPubMed Moores L, Aujesky D, Jiménez D, et al. Pulmonary Embolism Severity Index and troponin testing for the selection of low-risk patients with acute symptomatic pulmonary embolism. J Thromb Haemost. 2010;8:517–22.CrossRefPubMed
Metadaten
Titel
The accuracy of combined use of troponin and red cell distribution width in predicting mortality of patients with acute pulmonary embolism
verfasst von
Selçuk Yazıcı, MD
Tuncay Kırış, MD
Ufuk S. Ceylan, MD
Şükrü Akyüz, MD
Ahmet O. Uzun, MD
Recep Hacı, MD
Sait Terzi, MD
Abdullah Doğan, MD
Ayşe Emre, MD
Kemal Yeşilçimen, MD
Publikationsdatum
01.12.2016
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe Sonderheft 8/2016
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-016-1081-y

Weitere Artikel der Sonderheft 8/2016

Wiener klinische Wochenschrift 8/2016 Zur Ausgabe